Overview

Implantoplasty entails polishing of the implant surface during the surgical therapy of peri-implantitis. Given the controversy behind implantoplasty as surface decontamination method in the treatment of peri-implantitis, the goal of this clinical trial is to assess the clinical resolution and radiographic bone gain in peri-implantitis sites treated by means of reconstructive therapy (Inteross® + autogenous bone, Sigmagraft, CA, USA) + implantoplasty in combined defects when compared to the extent of implantoplasty along the exposed implant surface upon the clinical resolution and radiographic bone gain in peri-implantitis sites treated by means of reconstructive therapy (Inteross® + autogenous bone, Sigmagraft, CA, USA).

Eligibility

Inclusion criteria

• All patients in age of 18 to 80, non-smokers
• With no presence of systemic disease or medication known to alter bone metabolism, and partial or complete edentulous patients that have no active periodontal disease.
• Peri-implantitis defined according to the EFP/AAP consensus meeting
• Combined defect configuration

Exclusion criteria:

• Pregnancy or lactation
• History of or current smokers
• Uncontrolled medical conditions,
• Cement-retained restoration
• Lacking keratinized mucosa (≤2mm) on the lingual or buccal implant sites.